Thesis (Ph.D. in Pharmacology) -- University of Colorado, 2005. / Typescript. Includes bibliographical references (leaves 145-170). Free to UCDHSC affiliates. Online version available via ProQuest Digital Dissertations;

Thesis (M.S.)--Brigham Young University. Dept. of Chemistry and Biochemistry, 2006. / Includes bibliographical references (p. 27-30).

Thèse (Ph.D.)--Université Laval, 2003. / Bibliogr.: f. [247]- 269. Publié aussi en version électronique.

Thesis (Ph. D. in Physics)--Vanderbilt University, May 2006. / Title from title screen. Includes bibliographical references.

Thesis (Ph. D.)--Ohio State University, 2006. / Full text release at OhioLINK's ETD Center delayed at author's request

Thesis (MSc (Genetics. Plant Biotechnology)--University of Stellenbosch, 2009. / ENGLISH ABSTRACT: Glycogen was isolated from E. coli and analysed for the amount of phosphate present within it. It was confirmed that a significant proportion of the glucose residues were phosphorylated at the C6 position. This glycogen phosphate was found also in both glgb- (glycogen branching enzyme) and glgp- (glycogen phosphorylase enzyme) mutants, demonstrating that a mechanism for phosphate incorporation that does not involve GlgP alone, and which is capable of incorporating phosphate into linear glucans could exist. The degree of phosphorylation depended on the amount of phosphate present in the media, which less being incorporated in media where phosphate was reduced. Screening for glycogen phosphorylating genes using a E. coli genomic library in a functional expression system identified the malP gene as a possible candidate for incorporation of the phosphate at the C6 position. There was no difference, however, between the glycogen phosphate content of the mutant and wild type. Efforts were made to construct a malp-/glgp- double mutant, but these were unsuccessful. In addition the influence of plants and human proteins on yeast glycogen metabolism was also investigated. These proteins have been demonstrated to have an effect on starch or glycogen in humans, plant and E. coli, but the data from this study indicated that this was not the case in yeast. / AFRIKAANSE OPSOMMING: Glikogeen, wat geisoleer was uit E.coli was geanaliseer vir fosfaat inhoud daarin. Daar was gevind dat `n beduidende proporsie van die glukose residue gefosforileerd was op die C6 posisie. Hierdie gefosforileerde glikogeen was ook gevind in glg- (glikogeen vertakkingsensieme) en glgp- (glikogeen fosforileringsensieme) mutante wat daarop dui dat `n meganisme vir fosforilering bestaan was nie slegs aangewese is op die aktiwiteit van GlgP nie, en om fosfaat te inkorporeer in linêre glukane. Die graad van fosforilering was ook afhanklik van die hoeveelheid fosfaat teenwoordig in die medium, met gevolglik minder wat geinkorporeer kan word in medium waar fosfaat verminderd was. Seleksie-gebaseerde ondersoeking vir fosforileringsensieme van glikogeen deur gebruik te maak van E. coli genomiese biblioteke in `n funksionele uitdrukkingssisteem het die malP geen geidentifiseer as een van die moontlike kandidate wat verantwoordelik kan wees vir inkorporering van fosfaat in the C6 posisie. Daar was egter geen verskil in die fosfaat inhoud van glikogeen tussen die wilde tipe en die mutante. Pogings wat aangewend is om `n malp-/glgpdubbel mutant te konstrueer was onsuksesvol. Verder is die invloed van plant en mens proteine op gis glikogeen ook bestudeer. Vroeër is aangetoon dat hierdie proteine `n invloed op stysel en glikogeen het in mense, plante en E. coli, maar data van hierdie studie toon aan dat dit nie die geval in gis is nie.

La prévalence de l’obésité est en constante augmentation dans les pays occidentaux, en raison d’une sédentarisation accompagnée d’une alimentation malsaine. L’obésité est souvent associée à une dysfonction endothéliale et à un risque athérogène élevé. Plusieurs observations cliniques ont montré que la modification du mode de vie, incluant la pratique régulière d’une activité physique et l’adoption d’un mode alimentaire sain, représente une stratégie efficace pour combattre l’obésité et ses complications cardiovasculaires. Cependant, de nombreux mécanismes précisant les effets thérapeutiques directs de l’exercice physique sur le risque athérogène lié à l’obésité sont encore largement inconnus. Le but principal de ce travail a donc été d’identifier, en utilisant un modèle de rat rendu obèse par un régime enrichi en graisse, les mécanismes athéro-protecteurs de l’exercice physique seul et/ou associé à une modification du régime alimentaire (du régime riche en graisse au régime standard). Nos résultats montrent que l’exercice physique, indépendamment de la diète utilisée, corrige la dysfonction endothéliale installée au cours de l’obésité. Cet effet bénéfique a été associé à une diminution du stress oxydatif au niveau vasculaire. En effet, nos résultats indiquent que l’exercice diminue l’activité de la NADPH oxydase au niveau aortique. De plus, nous montrons pour la première fois que l’exercice physique seul, indépendamment de la diète utilisée, est capable de moduler la translocation de la sous-unité de la NADPH oxydase p47phox (principal acteur dans l’activation de ce complexe enzymatique) vers la membrane. Nos résultats indiquent également que l’exercice physique, avec ou sans modification du régime, améliore la voie Akt/eNOS phosphorylée, suggérant une augmentation de la production du NO. Ainsi, l’exercice physique, même sans l’associer à un changement du mode alimentaire, peut être considéré comme une stratégie non-pharmacologique efficace pour le traitement du risque athérogène généré par l’obésité / The prevalence of obesity is increasing at an alarming rate in the western countries. It has been attributed to sedentariness and abundance of unhealthy food. Obesity is often associated with endothelial dysfunction and a high atherogenic risk. Several clinical investigations have reported that life style modification included physical exercise and the adoption of healthydiet was an efficient strategy to combat cardiovascular complications linked to obesity. However, numerous mechanisms by which exercise exerts the direct therapeutic effect on atherogenic risk linked to obesity are still unknown. Using the experimental model of high fat diet-induced obesity rat, the general aim of this study, was to identify the possible molecularmechanisms through which exercise with or without diet modification (high fat to standard diet) exerts an antiatherogenic action. Our results show that exercise independently of diet used, corrected the endothelial dysfunction induced by obesity. This benefit effect was associated with the decreased vascular oxidative stress. In effect, our results show that exercise alone was able to decrease NADPH oxidase activity in aortic tissue. Furthermore, we show for the first time that exercise, independently diet used, was able to modulate the translocation of p47phox subunit to membrane (which plays a pivotal role in NADPH oxidase activation). Ours results show also, that exercise with or without diet modification improves the Akt/eNOS phosphorylation pathway, suggesting that exercise increases NO production. In summary, exercise training even without diet modification, may be a non-pharmacological strategy treatment for atherogenic risk linked to obesity

Mitochondrial ATP synthase represents the final complex of oxidative phosphorylation (OXPHOS) system located in the inner mitochondrial membrane. Its primary role is to utilize mitochondrial membrane potential (Δψm) generated by respiratory chain complexes to produce energy in the form of ATP. Mammalian ATP synthase comprises of 17 different subunits organized into membranous Fo and matrix-oriented F1 domains. Defects of complex V and their manifestation have been studied on mitochondrial, cellular, tissue and organism levels using different models, including human cell lines and cell lines derived from patient tissues. In many cases mitochondrial diseases display threshold behaviour, when genetic defect is phenotypically manifested only bellow certain threshold in particular enzyme complex activity and/or content. This work was aimed at elucidation of functional consequences of ATP synthase deficiency in HEK293 cell lines with suppressed gene expression of γ, δ or ε subunits of ATP synthase central stalk. We have analysed range of clones with respective subunits knockdown and found varying decrease in assembled ATP synthase content, which was mirrored by the decrease in individual ATP synthase subunits. The only exception was subunit Fo-c, whose levels remained unchanged or even increased. ATP...

La recrudescence de la tuberculose et l'apparition des souches de Mycobacterium tuberculosis (Mtb) résistantes aux antibiotiques souligne la nécessité de rechercher de nouveaux antituberculeux avec de nouveaux mécanismes d'action. Les mycobactéries possèdent une membrane externe (appelée aussi mycomembrane), très riche en lipides qui leur confère une imperméabilité remarquable. Les constituants majeurs de la mycomembrane sont des acides gras originaux et à très longue chaine, appelés acides mycoliques (AMs). La biosynthèse de ces AMs est essentielle à la croissance mycobactérienne et comporte des enzymes-clefs, dont nombreuses ont été validées comme des cibles prometteuses pour la recherche de nouveaux antituberculeux. Parmi elles, FadD32, une Fatty-acyl AMP Ligase impliquée dans l'étape ultime de cette voie de biosynthèse. Si les propriétés physico-chimiques de l'enzyme ont été caractérisées, la régulation de l'activité de cette enzyme essentielle reste encore à découvrir. La première partie de cette thèse porte sur la mise en évidence de la régulation post-traductionnelle par phosphorylation de FadD32 par des Sérine/Thréonine Protéine Kinases (STPKs) de type eucaryote. Nous avons montré que FadD32 pouvait être phosphorylée in vitro par plusieurs STPKs de Mtb. Cette phosphorylation réversible module négativement l'activité de la protéine, comme démontré pour d'autres protéines de la voie de biosynthèse des AMs. Afin de mieux comprendre l'impact de la phosphorylation par STPK sur la production des AMs et sur la synthèse de la mycomembrane, nous avons surexprimé une STPK de Mtb chez M. smegmatis, espèce modèle des mycobactéries. Nous avons pu observer un changement significatif de la quantité des AMs. Dans la deuxième partie de la thèse, nous avons optimisé et réalisé le criblage biochimique d'une chimiothèque sur l'activité de FadD32 et avons identifié des touches qui devraient servir dans la recherche de nouveaux agents antituberculeux. / The resurgence of tuberculosis (TB), together with the emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb), highlights the need for new anti-TB drugs with novel mechanisms of action. Mycobacteria possess an outer membrane (also called mycomembrane), which confers to them a remarkably impermeable cell envelope. The major constituents of the mycomembrane are very long-chain fatty acids with original structures, the so-called mycolic acids (MAs). The biosynthesis of MAs is essential for mycobacterial growth and involves several key enzymes, many of which have been validated as promising anti-TB drug targets. Among them, FadD32, a Fatty-acyl AMP Ligase implicated in the last step of the biosynthesis pathway, has been characterized biochemically and its protein structure has been solved recently. However, the regulation aspect of the enzyme is still to be deciphered. The first part of the thesis focuses on the post-translational regulation by protein phosphorylation of FadD32 by eukaryotic-like Serine/Threonine Protein Kinases (STPKs). We showed that FadD32 is the substrate of several Mtb STPKs. The reversible phosphorylation negatively modulates the adenylation activity of the protein. In order to determine the impact of the post-translational regulation on MA production, we over-expressed a STPK of Mtb in M. smegmatis, a validated surrogate of Mtb. We observed a significant change in the amounts of MAs. In the second part of the thesis, we screened a chemical library against FadD32 and identified several hits that should help in the development of new anti-TB agents.

Mechanistic aspects of phosphorylation, dephosphorylation, pyrophosphorylation and depyrophosphorylation reactions that mimic phosphorylases, dephosphorylases, pyrophosphorylases and depyrophosphorylases have been studied in the biologically important middle pH region. The different systems monitored are; (a) the reactions between [{CoN4(OH)(OH2)}]2+ and [HPO4]- for 1:1, 2:1 and 3:1 [{CoN4(OH)(OH2)}]2+ to [HPO4]2- ratios. (b) the reactions between [{CoN4PO4] and [O2NC6H4O]- (abbreviated as NP-) for 1:1, 2:1 and 3:1 [{CoN4PO4] to [O2NC6H4O]- ratios. (c) the reactions between [{CoN4(OH)(OH2)}]2+ and [O2NC6H4PO4]2- (abbreviated as NPP2-) for 1:1, 2:1 and 3:1 [{CoN4(OH)(OH2)}]2+ to [O2NC6H4PO4]2- ratios. (d) the reactions between [{CoN4(OH)(OH2)}]2+ and [H2P2O7]2- for 1:1, 2:1 and 3:1 [{CoN4(OH)(OH2)}]2+ to [H2P2O7]2- ratios. (e) the reactions between [{CoN4P2O7}]- and [O2NC6H4O]- for 1:1, 2:1 and 3:1 [{CoN4P2O7}]- to [O2NC6H4O]- ratios. Significant phosphorylation was noted for systems containing 1:1 molar ratio [{CoN4PO4] and [O2NC6H4O]-. Enhanced phosphorylation was depicted for system containing 1:1 molar ratio of [{CoN4(OH)}2PO4]+ and [O2NC6H4O]-. Pyrophosphorylation was noted for reactions of 1:1 molar ratio of [{CoN4P2O7}]- and [O2NC6H4O]-. The rate of pyrophosphorylation was substantially reduced for systems that were 2:1 in molar ratio of [{CoN4P2O7}]- and [O2NC6H4O]-. No appreciable pyrophosphorylation was noted for systems, which has a 3:1 molar ratio of [{CoN4P2O7}]- and [O2NC6H4O]-. Specific mechanistic features and the possible roles metal ions play in phosphorylase, dephosphorylase and pyrophosphorylase are highlighted from results of UV-Visible spectroscopy, 31P {1H} NMR spectroscopy and Surface Enhanced Raman Scattering (SERS) studies / Chemistry / D.Phil. (Chemistry)